Israel’s EarlySense Ltd. has secured a $25m series G round of funding, bringing the total amount it has raised from investors to date to more than $100m. The funding round, announced on June 1, will be used to drive growth of its FDA-cleared and CE-marked contact-free continuous monitoring technology. EarlySense says it is the market leader in the space with its under-mattress sensor devices.
The new funding round was led by Israel’s Bank Hapoalim, with participation from Pitango Venture Capital and JK&B Capital, among others
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?